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Determining individual health status is of great importance for a better understanding of
life history trade-offs between growth, reproduction, and maintenance. However, existing
immunological methods are invasive and therefore not suitable for investigating health
status in wild populations. Thus, there is an urgent need for non-invasive methods to
assess the immune status of animals. Neopterin is involved in the cell-mediated pathway
of the immune response (Th1–type), secreted during the activation of monocytes and
macrophages. We investigated if urinary neopterin could serve as a biomarker of health
status in bonobos and chimpanzees. First, we performed a chemical validation of a
commercial neopterin enzyme immune assay (EIA) for bonobo and chimpanzee urine.
We then examined if urinary neopterin levels in bonobos increase during the acute period
of respiratory infections. We found that neopterin levels can be reliably measured in urine
of the two species with a commercial EIA. Stability experiments revealed considerable
changes in urinary neopterin levels in relation tomultiple freeze–thaw cycles and extended
exposure to room temperature. Exposure to sunlight led to a degradation of urinary
neopterin, whereas sample storage up to 2 years did not affect urinary neopterin
levels. There was no detectable diurnal variation in neopterin levels, and levels remained
very stable across several days in healthy individuals. While urinary neopterin levels
were independent of sex, non-adult individuals had higher urinary neopterin levels than
adults. Most importantly, there was a significant increase in urinary neopterin levels
during a period of respiratory infection. Our results demonstrate that regular urine
sample collection would allow for the monitoring of individual health status and disease
progression with minimal disturbance of the subjects. In combination with behavioral,
life history, and endocrinological parameters, the method can be used to investigate
questions related to immunocompetence handicaps or life history trade-offs.
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INTRODUCTION
Understanding life history trade-offs between growth,
reproduction, and the maintenance of health is of major
importance in the field of integrative biology (Stearns, 1992). The
maintenance of a well-functioning immune system is essential
for resistance to infections and ultimately for survival (French
et al., 2009). Therefore, determining individual health status is
important for a better understanding of the course of diseases,
intra- and interspecific transmission, and ultimately the effects
of health status on fitness (Lazzaro and Little, 2009).
Immunology has traditionally been studied in laboratory
animals with a focus on proximate mechanisms and functionality
of the immune system (Pedersen and Babayan, 2011). The
laboratory environment permits highly controlled conditions,
facilitates repeated testing, variation of environmental
parameters, and the manipulation of infections (Lazzaro
and Little, 2009; Pedersen and Babayan, 2011), thereby excluding
co-factors and allowing for a clear link between factors analyzed.
While results of laboratory tests can be informative in terms of
the trade-offs between activation of immune function on the
one hand and growth and reproductive performance on the
other hand. Such tests do not account for the effects of other
parameters that are of importance in natural populations such
as individual coevolution of pathogens and the host’s immune
response under conditions of limited access to resources,
infection risk, and genetic diversity (Sheldon and Verhulst, 1996;
Lazzaro and Little, 2009; Pedersen and Babayan, 2011).
Ecoimmunological studies on non-human primates have
aimed at the ecology of, for example, infectious diseases
(Chapman et al., 2005; Nunn, 2012), the spread of sexually
transmitted diseases (Nunn et al., 2014), parasite and disease
transmission (Côté and Poulin, 1995; Bonnell et al., 2010), as well
as transmission between humans and wildlife (Daszak et al., 2000;
Köndgen et al., 2008). Due to the lack of non-invasive techniques
for the determination of the immune status, patterns of immune
response are comparatively less well-studied in wild and captive
non-human primates. So far, the health status of captive and
wild primates was mainly assessed invasively by measuring
immune parameters in blood samples (Eberl et al., 2001; Howell
et al., 2003; Prall et al., 2015). While this approach facilitates
the use of analytical techniques that have been developed for
human research, the manipulation of animals for blood sampling
increase the risk of injury. Furthermore, because of its invasive
nature, this approach is not suitable for longitudinal studies
such as the long-term monitoring of changes in parasite load,
fluctuation of disease transmission, and age-related changes in
immune competence, especially in wild-living animals. Thus,
there is an urgent need for techniques that can non-invasively
assess the immune status of animals.
Previously, non-invasive assessment of health status in non-
human primates was carried out by, e.g., visual inspection
(Archie et al., 2012), or by quantification of parasitic load
(Gillespie et al., 2005). Urinalysis was used in non-human
primates to diagnose urologic conditions or diseases of the
kidneys (Simmerville et al., 2005). In urine of wild chimpanzees,
urinalyses were performed using dipsticks (Kaur and Huffman,
2004; Kelly et al., 2004; Krief et al., 2005; Leendertz et al., 2010).
Unfortunately, the results of dipstick analyses alone turned out
to be an unreliable method for assessing the health status of these
animals, because the concentration of proteins in the urine was
not associated with obvious external signs of illness (Kaur and
Huffman, 2004; Leendertz et al., 2010).
An approach that has received far less attention thus far
in the context of studying diseases non-invasively in non-
human primates is the activation of the immune response which
plays a key role in fending off diseases and infections (Murr
et al., 2002). The non-specific immunity or innate immunity
responds to pathogens without establishing a long-lasting or
protective immunity to the host. Parts of the specific and non-
specific immune responses are T–cells, including the T helper
cells (Th–cells). After antigen recognition, the Th–cells release
interleukin 12 (IL–12), which activates the T lymphocytes type
1 and natural killer cells to release interferon–γ. In conjunction
with interferon–α, other cytokines, and endotoxins, interferon–
γ stimulates the activation of monocytes/macrophages. When
stimulated, these cells release neopterin into body fluids.
Therefore, an eventual increase in neopterin levels occurs
whenever T helper cells have been activated. In humans, this
cell-mediated (Th1–type) pathway of immune response can be
monitored by measuring changes of neopterin levels (Huber,
1984; Fuchs et al., 1988; Murr et al., 2002). Neopterin, 2–
amino–4–hydroxyl–6–(D–erythro-1′, 2′, 3′–trihydroxypropyl)—
pteridine, belongs to the class of aromatic pteridines. Unlike
interferon–γ, which quickly degrades and has a tendency of
binding to pathogens, neopterin is chemically stable and excreted
in an unchanged form by the kidneys into urine (Berdowska and
Zwirska-Korczala, 2001). Because neopterin is constantly present
in all body fluids, it can also be measured in urine samples (Murr
et al., 2002), which can be collected non-invasively from wild and
captive animals. During the course of a virus infection, neopterin
levels start to decline after specific antibodies against the antigen
are measurable, and stay at baseline levels when the immune
system has successfully defeated the infection (Murr et al., 2002).
Therefore, changes in neopterin levels are closely associated with
the activation of the early cellular immune response (Hamerlinck,
1999; Pingle et al., 2008).
In humans, an increase in serum and urinary neopterin
levels can be observed in patients with various inflammatory
diseases during the acute phase of infection, e.g., acute viral (such
as hepatitis and rubella) and intracellular bacterial infections
(such as pulmonary tuberculosis and leprosy) as well as in
patients with chronic infections or tumors (Huber, 1984;
Hamerlinck, 1999; Widner et al., 1999; Schennach et al., 2000).
In summary, neopterin measurement provides an insight into
cell-mediated immune response and allows for the monitoring
of disease progression (Berdowska and Zwirska-Korczala, 2001).
As neopterin is involved in the non-specific immune response,
it can be used as a marker to identify the health status of
individuals for which the exact disease is not yet identified.
In this study, we evaluate the potential practicality of non-
invasive measures of neopterin for monitoring immune system
functioning in urine samples of bonobos (Pan paniscus) and
chimpanzees (Pan troglodytes). We tested whether neopterin can
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be reliably measured in urine samples of the two ape species.
Furthermore, we investigated the stability of urinary neopterin
at room temperature, when urine samples were stored at minus
20◦C for 2 years (long-term storage), after repeated freeze-thaw
cycles, and after exposure to sunlight. In addition, we explored
if a diurnal pattern in urinary neopterin excretion exists as well
as how stable urinary neopterin levels are in healthy individuals
during a week, and we investigated sex and age effects on urinary
neopterin levels. Finally, we analyzed the diagnostic potential
of urinary neopterin levels comparing samples from the same
bonobo during a period of respiratory disease with samples
collected during a period of health.
MATERIALS AND METHODS
Ethics Statement
All urine samples were collected non-invasively. The study
was carried out in accordance with NIH published standards.
The protocol for urine sample collection was approved by the
authorities of each zoo. All animals were housed in social
groups in European zoos. The apes received a mix of fruits and
vegetables several times per day and had ad libitum access to fresh
water.
Animals and Sample Collection
We used 66 samples from 21 male and female bonobos and
10 samples from male and female chimpanzees, collected in 11
different zoos (Table 1). The chimpanzees ranged from 18 to
49 years of age and the bonobos ranged from 2 to 52 years
(Table 1). Urine samples were randomly collected throughout the
day. Samples were collected by the keepers directly from the urine
stream or taken off the ground, when the individual could be
identified and when contamination with feces could be excluded.
For detailed description see Behringer et al. (2014).
Urine samples were collected and experiments were carried
out between February 2012 and August 2016. Samples of
both species were used to test the effects of different ambient
conditions on urinary neopterin levels including: the freeze-
thaw cycles, storage at room temperature, long-term storage
for 2 years, and exposure to sunlight. Samples used for these
experiments were collected throughout the day (between 7:00
and 18:00) and came from subjects living in different zoos
(Table 1). In detail, the freeze-thaw experiment was performed to
assess urinary neopterin level stability in the samples. We pooled
urine samples of three males and three females from each species,
took five aliquots from each pooled sample, and exposed them to
an increasing number (1–5) of freeze-thaw cycles. To examine
the degradation of urinary neopterin over a period of 48 h at
room temperature (23◦C), two pooled samples were prepared as
described above. Five aliquots were kept at room temperature,
and then frozen after 1, 4, 8, 24, and 48 h, respectively. To assess
degradation after long-term storage (at −20◦C), aliquots of the
seven original samples measured in July 2014 were measured
again in July 2016. For the sunlight experiment, aliquots of 200
µl urine from four individuals were kept for 3 h (a) in the dark
at room temperature, (b) at artificial light at room temperature,
TABLE 1 | Species, zoo, number of urine samples, and purpose of use for
measuring urinary neopterin.
Species Sex Age* Zoo No. of samples Used**
Bonobo f 9, 10 Planckendael 5 h, da, w
Bonobo f 18, 19 Planckendael 6 h, da, w
Bonobo f 35 Stuttgart 1 s
Bonobo f 25 Frankfurt 1 d
Bonobo f 27, 28 Planckendael 6 h, da, w
Bonobo f 5, 6 Planckendael 6 h, da, w
Bonobo f 52 Frankfurt 1 s
Bonobo f 12 Frankfurt 1 se
Bonobo f 2 Planckendael 4 h, da, w
Bonobo f 5 Frankfurt 1 se
Bonobo f 30 Leipzig 1 s
Bonobo f 14, 15 Frankfurt 3 h, d, r
Bonobo m 7, 8 Planckendael 6 h, da, w
Bonobo m 11, 12 Frankfurt 5 d, h, s, se, r
Bonobo m 21 Leipzig 1 s
Bonobo m 28 Frankfurt 2 d, s
Bonobo m 14, 15 Planckendael 6 h, da, w
Bonobo m 7 Frankfurt 2 h
Bonobo m 4 Frankfurt 2 h, r
Bonobo m 2 Frankfurt 1 se
Bonobo m 18, 19 Planckendael 5 h, da, w
Chimpanzee f 38 Halle 1 s, r
Chimpanzee f 46 Aalborg 1 d
Chimpanzee f 38 Heidelberg 1 s
Chimpanzee f 11 Badoca 1 d
Chimpanzee f 39 Heidelberg 1 s
Chimpanzee m 18 Augsburg 1 s, r
Chimpanzee m 19 Badoca 1 d
Chimpanzee m 25 Copenhagen 1 d
Chimpanzee m 49 Kittenberger 1 s, r
Chimpanzee m 37 Halle 1 s
*Age, age at sample collection.
**d, dilution; da, daily variation; h, health status; s,stability test; se, sunlight exposure;
r, re-measurement after 2 years; w, weekly comparison.
(c) at direct sunlight, and (d) at sunlight on ice packs to exclude
temperature effects.
Urine samples from bonobos were used to assess diurnal
variation, weekly changes, sex- and age-specific variation, as
well as within individual comparison of urinary neopterin levels
when being sick vs. healthy (Table 1). To assess diurnal variation,
samples from eight bonobos were collected in Planckendael Zoo
at 7:00, 12:00, and 17:00, and for temporal changes twice in 1
week at 7:00. To evaluate the impact of age and sex, samples of
healthy bonobos (Nfemales = 7, Nmales = 6) were collected in
Planckendael and Frankfurt Zoo. For investigating the impact
of disease on urinary neopterin levels, we conducted a within
subject comparison of 22 bonobos housed in Planckendael and
Frankfurt Zoo during periods when the individuals were either
healthy or sick (Table 1). Urine was collected opportunistically
during a period of illness (sick sample) when the animals were
diagnosed with an unspecific respiratory disease accompanied by
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running noses and coughing. During the period when symptoms
were visible, one sample was collected from each individual at
Frankfurt Zoo between the 11th and 12th March 2014, and at
Planckendael Zoo between the 27th of February and the 1st
of March 2013. Although daily documentation by zookeepers
verified that all animals showed symptoms of a respiratory
disease, it was not possible to reproduce the exact time course
of the disease for each animal. After convalescence, we collected
an additional sample from the same individual (healthy sample).
After collection, all urine samples were stored at −20◦C in
the zoos and transported frozen to the Max Planck Institute for
Evolutionary Anthropology (MPI-EVA), Leipzig, Germany. At
theMPI-EVA samples, were stored at−20◦C until analysis. More
detailed information on urine sample collection can be found in
Behringer et al. (2014).
Urinary Neopterin Measurement with an
ELISA
To measure neopterin levels in urine of bonobos and
chimpanzees, we used a commercial competitive neopterin
ELISA (Neopterin ELISA, Ref. RE59321, IBL International
GmbH, Hamburg, Germany), which was created for the
quantification of neopterin in human serum, plasma, and
urine. For analyses, all urine samples were thawed, vortexted,
centrifuged, and diluted 1:100 with the assay buffer of the
supplier. The assay was performed following the instructions
from the supplier. We took 20 µl of the diluted urine, 100 µl
of the enzyme conjugate, and added 50 µl of the neopterin
antiserum to each well on the plate. The plate was incubated in
the dark for 90 min. After incubation, plate was washed four
times with washing buffer, and 150 µl of tetramethylbenzidine
substrate solution was added. The reaction was stopped after 10
min. of incubation with 150 µl of the provided stop solution.
Optical density was measured photometrically at 450 nm. All
samples, standards, and controls were measured in duplicate.
Inter-assay variation of four separate runs for high- and low-
quality controls was 6.2 and 7.7%, respectively. Intra-assay
variation was 6.1% (N = 42 samples). Results are expressed in
nmol/L.
To compensate for variation in volume and concentration of
the collected urine, specific gravity (SG) was measured with a
digital handheld refractometer (TEC, Ober-Ramstadt, Germany).
SG population average for the measured bonobo urine samples
was 1.0095. No correction factor was needed for the chimpanzee
urine, because the results were only used for within sample
comparison. The correction for neopterin concentration for each
bonobo sample was calculated as described in Miller et al.
(2004). Final results are expressed in urinary neopterin (nmol/L)
corrected for SG (corr. SG).
Assay Validation
To test the reliability of neopterin measurements in urine
samples, the assay was validated by (a) parallelism and (b) an
accuracy test for each species.
(a) For assessment of parallelism, four samples from each species
(two males and two females) were pooled and serially diluted
with the provided buffer of the assay kit (25-, 50-, 100-, 200-,
and 400-fold).
(b) To assess the assay accuracy of the neopterin measurement,
we pooled six samples (three females and three males) from
each species. Each pool sample was spiked with 1.35, 4, and
12 nmol/l of standard provided by the assay kit, respectively.
Statistical Analysis
To assess the effect of sampling day (samples collected twice
per week), long-term storage (freezing for 2 years), and for
comparing urinary neopterin levels in samples collected during
healthy and sick periods, we ran an exact Wilcoxon test for
each data set. Additionally, for the long-term storage, we ran a
Spearman rank correlation on the urinary neopterin measures.
To compare urinary neopterin levels between females and males
we used a two tailed t-test. All tests were run in R (R Core Team,
2016).
RESULTS
Assay Validation
Serially diluted pooled urine samples were parallel to the
neopterin standard curve in both species (Figure 1).
Average recovery of spiked urine samples was 99.3% (range:
75–114%) for bonobos and 100.3% (range: 80–122%) for
chimpanzees. In both species, higher recovery was achieved in
samples that were spiked with higher concentrations of neopterin
(Table 2).
Stability of Urinary Neopterin Levels in
Bonobos and Chimpanzees
Freeze-Thaw Cycle Experiment
Repeated freeze-thaw cycles (range: 1–5 times) of urine samples
led to an increase of the original measured urinary neopterin
levels in both species (Figures 2A,B). In bonobos, urinary
neopterin levels increased to 120% after the first thawing cycle,
FIGURE 1 | Optical density of serial dilutions of two spiked pooled
urine samples from chimpanzees and bonobos in relation to the
standard curve.
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then decreased to 105% after the second cycle, and returned to
about 120% thereafter for the remaining cycles (Figure 2A). In
chimpanzee samples, urinary neopterin levels reached 145% after
the first thawing cycle and stayed between 130 and 140% for the
following four cycles (Figure 2B).
Room Temperature Experiment
In pooled urine samples stored for 4 h at room temperature,
urinary neopterin levels decreased by approximately 20% in
both species (Figures 3A,B). In the bonobo pooled sample,
urinary neopterin levels increased consecutively after 8 and 24
h and remained at the 24 h level thereafter (Figure 3A). In
chimpanzees, urinary neopterin levels also increased after 8 h,
and decreased again after 24 h (Figure 3B).
Long-Term Storage Experiment
After 2 years of storage, on average 90% of the first neopterin
measurement was re-measured. In one individual, urinary
neopterin was degraded by more than 40% (Table 3). Overall,
urinary neopterin levels at the beginning and after 2 years of
storage showed no significant differences (exact Wilcoxon test:
T+ = 1.69, N = 7, P = 0.144), and were significantly positively
correlated (rspearman = 0.96, P = 0.002, N = 7).
TABLE 2 | Accuracy of urinary neopterin measurements in pooled
samples (1:100 diluted with the assay buffer) spiked with three different
concentrations of neopterin.
Species Standard Neopterin [nmol/L] Recovery (%)
Pool sample Expected Measured
Bonobo 1.35 1.74 1.99 114
4 3.49 3.81 109
12 8.37 6.28 75
Chimpanzee 1.35 2.25 2.74 122
4 3.45 3.42 99
12 8.81 7.05 80
Sunlight Exposure Experiment
Urinary neopterin levels in samples stored in the dark compared
with storage in artificial light changed only slightly in two of
three samples (Table 4). In samples exposed for 3 h to sunlight,
the neopterin concentration was not measurable any more, even
when the samples were cooled during this period (Table 4).
Diurnal Variation
Urinary neopterin levels in samples of eight bonobos showed no
obvious diurnal pattern (Figure 4). The largest effect size was in
one adult male whose urinary neopterin level was approximately
20% lower in the evening (452.2 nmol/L corr. SG) compared
with the morning sample (579.8 nmol/L corr. SG). The average
effect size was 1.1 between morning/noon, morning/evening,
and noon/evening. Urinary neopterin levels differed between
individuals, and ranged from 323 nmol/L corr. SG to 1153.1
nmol/L corr. SG.
Weekly Changes
Urinary neopterin levels showed no significant differences over
the course of 1 week, consistent across eight different individuals
(T+ =−1.071, df = 7, P= 0.320, Figure 5). The average urinary
neopterin level change was 4.1% (range: 0.4–14.5%).
Sex and Age Comparison
There was no significant difference in urinary neopterin levels of
healthy male (N = 6) and female (N = 8) bonobos (T = 0.7532,
df = 10.445, P = 0.468), but the three youngest individuals (2, 6,
and 8 years of age) had the highest levels.
Comparison of Urinary Neopterin Levels in Sick and
Healthy Bonobos
A within individual comparison of urinary neopterin levels
(corr. SG) during healthy and sick periods showed significantly
higher urinary neopterin levels in bonobos with symptoms of a
respiratory disease (exact Wilcoxon test: T+ = 66, N = 11, P <
0.001, Figure 6).
FIGURE 2 | Urinary neopterin levels in pooled samples of (A) bonobos and (B) chimpanzees over the course of five freeze-thaw cycles.
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FIGURE 3 | Urinary neopterin levels in pooled samples of (A) bonobos and (B) chimpanzees kept at room temperature for 48 h.
TABLE 3 | Neopterin measures (nmol/L) in urine samples before (first
measurement) and after 2 years (second measurement) of storage at
−20◦C.
Sample no. First measurement Second measurement
Neopterin (nmol/L)
1 418 292
2 644 700
3 713 714
4 3491 3153
5 1184 996
6 783 833
7 980 749
We found that both average and median values of urinary
neopterin levels (nmol/L corr. SG) were higher in sick bonobos
than in healthy bonobos (Table 5). However, the variation in
urinary neopterin levels was greater in sick compared to healthy
individuals (presented by SD., Min., and Max. in Table 5). The
average effect size was 4.8 between healthy and sick neopterin
levels. The strongest effect size between the two conditions was
found in an adult female (effect size of urinary neopterin levels:
sick 13.3 times higher vs. healthy), and the smallest in an 8-year-
old male (effect size of urinary neopterin levels: sick 1.6 times
higher vs. healthy).
DISCUSSION
This study demonstrates that neopterin levels can be reliably
measured in urine of bonobos and chimpanzees. The stability
experiments revealed that urinary neopterin levels increased
during multiple freeze-thaw cycles in both species. Additionally,
storing samples at room temperature for 4 h decreased urinary
neopterin levels in both species, but levels were unaffected by 2
years of long-term storage in the freezer. After 3 h of exposure
to sunlight, urinary neopterin levels were degraded below the
sensitivity threshold of the assay. The time of urine collection
TABLE 4 | Neopterin levels (nmol/L) in four urine samples after storage for
3 h in the dark, artificial light (light), sunlight with cool packs (sun and
cool), and sunlight without being cooled (sun).
Sample 1 2 3 4
Condition Neopterin (nmol/L)
Dark 129 3618 1294 2450
Light 197 3666 1218 2547
Sun and cool Too low Too low Too low Too low
Sun Too low Too low Too low Too low
during a day had no effect on neopterin levels; moreover, within
a 1-week period there was only minimal variance in the urinary
neopterin levels within an individual. While urinary neopterin
levels were independent of sex, age had an effect, with higher
urinary neopterin levels in samples from young individuals.
However, this effect should be statistically tested with a larger
sample size in future studies. Finally, while urinary neopterin
levels of healthy and sick individuals overlapped, there was a
significant increase of urinary neopterin levels during a time of
a respiratory infection.
We validated a commercial assay originally developed to
measure neopterin in human serum and urine. We extended
the validation of the assay kit for bonobos and chimpanzees.
This validation for each species is an essential requirement
for measuring physiological markers extracted from organic
substances like urine or fecal samples (Buchanan and Goldsmith,
2004). The chemical validation, including serially diluted urinary
neopterin and recovery of spiked urine samples, revealed that
neopterin can be reliably measured in urine samples of bonobos
and chimpanzees.
The second part of the study explored the stability of neopterin
in urine samples of bonobos and chimpanzees with changing
ambient conditions. It is essential to explore the effect of different
ambient conditions, because biological markers in samples are
vulnerable to degradation (Buchanan and Goldsmith, 2004). We
found that in samples from both species, urinary neopterin levels
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FIGURE 4 | Variation of urinary neopterin levels (nmol/L) corrected for specific gravity (corr. SG) collected at 7:00 h (morning, N = 8), at 12:00 h (noon,
N = 5), and at 17:00 h (evening, N = 8) from eight different bonobos.
FIGURE 5 | Urinary neopterin levels (nmol/L) corrected for specific gravity (corr. SG) in samples from eight bonobos collected twice in 1 week.
increased with the number of freeze-thaw cycles. In human
serum, neopterin levels are also known to be affected by frequent
thawing cycles, and in macaques, urinary neopterin significantly
increased after three freeze-thaw cycles (Heistermann and
Higham, 2015). Therefore, we recommend to avoid freeze-thaw
cycles of the samples or at least to keep the number of freeze-thaw
cycles constant for all samples.
When urine samples were kept at room temperature for a
period of 24 or 48 h, urinary neopterin levels first decreased
and then increased in samples from both species. In a study
on macaques, urinary neopterin levels in samples exposed to
room temperature for 21 days increased gradually and elevation
reached a significant level at the second day of exposure to
room temperature (Heistermann and Higham, 2015). Therefore,
we recommend freezing the samples promptly after sample
collection and the preparation of dilutions. In terms of long-
term storage, the neopterin assay kit manual (Neopterin ELISA
RE59321) informs that urine samples could be stored for 6
month at −20◦C. After macaques urine was stored for an 8-
month period, urinary neopterin levels showed no statistical
degradation (Heistermann and Higham, 2015). We extended the
storage period to 2 years at −20◦C, and found that urinary
neopterin levels remained stable even after 2 years of storage at
−20◦C. These results indicate that urinary samples for neopterin
measurement could be stored at −20◦C for extended periods
of time without risking degradation. One parameter that did
lead to degradation of neopterin levels was sunlight (Müller
et al., 1991; Laich et al., 2002). In our experiment, 3 h of
exposure to sunlight were sufficient to degrade neopterin below
the assay’s sensitivity threshold. Accordingly, for studies aiming
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FIGURE 6 | Urinary neopterin levels (nmol/L) corrected for specific gravity (corr. SG) from 11 individuals collected at a time of acute illness and a time
without symptoms. The y-axis is displayed on a log scale.
TABLE 5 | Description of urinary neopterin levels (nmol/L corr. SG) in 11
bonobos during healthy and sick periods, as well as the effect sizes
between the two conditions.
Neopterin (nmol/L corr. SG) Effect size
Healthy Sick
Mean 655.0 3474.4 4.8
SD. 355.4 4891.9
Median 494.9 1356.6 3.2
Max. 1274.8 16913.9 13.3
Min. 273.1 463.6 1.6
at measuring urinary neopterin levels, we recommend avoiding
exposure of urine samples to sunlight, many repeated freeze-thaw
cycles, and sample storage at room temperature.
We found no clear pattern of diurnal variation in urinary
neopterin levels corroborating findings of other studies that
indicate that neopterin is produced and released in a remarkably
constant proportion (Murr et al., 2002), and that therefore,
daytime of sampling is trivial. Furthermore, we found only
modest variation of urinary neopterin levels across a 4-day
period. This confirms findings from a study on adult humans
that showed that serum neopterin levels were stable throughout 1
year, but increased during an influenza infection and afterwards
returned to baseline levels (Wachter et al., 1989). Consistent
with other studies in humans (Werner et al., 1987; Müller
et al., 1991; Diamondstone et al., 1994), and macaques (Higham
et al., 2015), we found that neopterin levels did not vary with
sex, but that there was considerable variation across healthy
adult individuals. Overall, this indicates that healthy individuals
have stable baseline neopterin levels; however, the causes for
inter-individual variation of urinary neopterin baseline levels
remain to be explored.
Our finding that younger individuals (less than 9 years of age)
had the highest urinary neopterin levels is in line with data from
human studies showing that urinary neopterin levels were higher
in subjects younger than 18 years of age (Werner et al., 1987),
and that the highest neopterin levels were measured in neonates
(Müller et al., 1991). Young children are facing an elevated
infection risk when attending daycare center, kindergarten and
school (Wald et al., 1991; Mikolajczyk et al., 2008). These
challenges to the immune system, when children come more
into close physical contact with other children, lead to frequent
increases in urinary neopterin levels (Winkler et al., 2003). In
young chimpanzees, social play and the number of play partners
increase in the first 3 years of life. Therefore, the risk of infection
increases in this life stage (Kuehl et al., 2008), which could
potentially lead to the higher neopterin levels described in this
study. However, the density of sample collection and numbers of
individuals does not allow us to make any firm conclusions.
In our study, there was no sex difference in urinary neopterin
levels corrected for specific gravity. This result is in line with
serum neopterin studies in healthy humans (Reibnegger et al.,
1988; Müller et al., 1991; Diamondstone et al., 1994; Satoh et al.,
1998) and macaques (Higham et al., 2015). Results of studies
investigating human urinary neopterin levels are ambiguous.
While some found no sex difference (Werner et al., 1987;
Hamerlinck, 1999), others found higher urinary neopterin levels
in women than in men (Hausen et al., 1982; Mura et al.,
1984). However, this sex difference is most probably an effect
of the correction of the urinary neopterin levels with creatinine.
Urinary creatinine levels correlate with muscle mass, therefore,
since men have higher muscle mass, they also have higher urinary
creatinine levels which lowers their corrected neopterin levels
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(Hausen et al., 1982; Fuchs et al., 1984; Reibnegger et al., 1986).
As with other biomarkers, when investigating sex differences in
urinary levels, a concentration correction with specific gravity
should be preferred over creatinine (Miller et al., 2004; Emery
Thompson et al., 2012).
During periods of unspecific respiratory infections, neopterin
levels in bonobo urine were significantly elevated in our study.
These results are consistent with prior studies, in which changes
in neopterin levels were used to track viral infection in macaques.
In macaques, urinary neopterin level increased after artificial
viral infection (Fendrich et al., 1989; Higham et al., 2015). In
human patients with pulmonary tuberculosis, researchers found
a correlation between mean neopterin levels and the extent of
disease (Fuchs et al., 1984). Furthermore, every disease associated
with intensified monocyte/macrophage response is accompanied
by increased neopterin levels (Berdowska and Zwirska-Korczala,
2001). Previous studies have shown that neopterin levels undergo
dramatic changes during the course of an infection (Murr et al.,
2002) and therefore, the diagnostic value of urinary neopterin
levels, e.g., the responsiveness of urinary neopterine excretion in
relation to the severity of the infection and/or the strength of
the immune response, depends on the timing of sampling within
the period of infection and repetition of sampling throughout
the entire infection period. Yet, the overlap of urinary neopterin
levels from healthy and sick individuals suggests that detection
of an acute infection depends on baseline samples from the
same individual. Consequently, it is not possible to define a
range of “healthy” neopterin levels and to distinguish them from
levels indicative of sickness. Instead, detection of an infection
or disease requires sampling over longer periods of time or
at least solid baseline values. Therefore, regular urine sample
collection would allow for the monitoring of individual health
status and disease progression via neopterin level changes. In
addition, the monitoring of immune status or frequency and
degree of infections in individuals in their natural habitat, in
combination with behavioral, life history, and endocrinological
parameters can be used to investigate questions in relation
to immunocompetence handicaps (Hamilton and Zuk, 1982;
Folstad and Karter, 1992; Roberts et al., 2004) or life history
trade-offs (French et al., 2009). Because such studies depend
on repeated measures of the immune status, the non-invasive
measurement of urinary neopterin levels would be the ideal
method of choice.
CONCLUSION
Our study demonstrates that urinary neopterin measurements
can be used to monitor aspects of the health status of captive
and wild-living apes with minimal disturbance of the subjects.
Following a similar validation protocol, urinary neopterin
measurements could become a valuable tool for non-invasive
health monitoring of other wild-living animal species. However,
since neopterin levels are highly variable across individuals,
baseline levels from urine samples during healthy periods
are needed for comparison to assess the health status of an
individual. Furthermore, neopterin levels are higher in non-adult
in comparison to adult individuals. To prevent degradation of
neopterin, urine samples need to be frozen as soon as possible
after collection, and repeated freeze-thaw cycles and sunlight
exposure should be avoided.
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